NEW YORK, Feb. 19, 2021 Pawar Law Group announces a class action lawsuit on behalf of shareholders who purchased shares of 9F Inc. from August 14, 2019 through September 29, 2020,.
NEW YORK, Feb. 19, 2021 (GLOBE NEWSWIRE) Pawar Law Group announces that a class action lawsuit has been filed on behalf of shareholders who purchased shares of Penumbra, Inc. (NYSE PEN) from August 3, 2020 through December 15, 2020, inclusive (the “Class Period”). The lawsuit seeks to recover damages for Penumbra, Inc. investors under the federal securities laws. To join the class action, go here or call Vik Pawar, Esq. toll-free at 888-589-9804 or email info@pawarlawgroup.com for information on the class action. According to the lawsuit, defendants made false and/or misleading statements and/or failed to disclose that: the Jet 7 Xtra Flex had known design defects that made it unsafe for its normal use; Penumbra did not adequately address the risk of Jet 7 Xtra Flex causing serious injury and deaths, which had in fact already occurred; the Jet 7 Xtra Flex was likely to be recalled due to its safety issues; and as a result, Penumbra’s public statements as set fort
NEW YORK, Feb. 19, 2021 (GLOBE NEWSWIRE) Pawar Law Group announces a class action lawsuit on behalf of shareholders who purchased shares of Exxon Mobil Corporation (NYSE: XOM) from November 6, 2019 through January 14, 2021, inclusive (the “Class Period”). The lawsuit seeks to recover damages for Exxon Mobil Corporation investors under the federal securities laws. To join the class action, go here or call Vik Pawar, Esq. toll-free at 888-589-9804 or email info@pawarlawgroup.com for information on the class action. According to the lawsuit, defendants made false and/or misleading statements and/or failed to disclose that: Exxon forced its employees to use unrealistic assumptions regarding the timelines for well drilling in the Permian Basin; the foregoing assumptions served to artificially inflate the value of the Company’s well operations in the Permian Basin; the foregoing conduct, when revealed, subjected Exxon to a heightened risk of regulatory investigation an
NEW YORK, Feb. 19, 2021 (GLOBE NEWSWIRE) Pawar Law Group announces a class action lawsuit on behalf of shareholders who purchased shares of Voyager Therapeutics, Inc. (NASDAQ: VYGR) from June 1, 2017 through November 9, 2020, inclusive (the “Class Period”). The lawsuit seeks to recover damages for Voyager Therapeutics, Inc. investors under the federal securities laws. To join the class action, go here or call Vik Pawar, Esq. toll-free at 888-589-9804 or email info@pawarlawgroup.com for information on the class action. According to the lawsuit, defendants made false and/or misleading statements and/or failed to disclose that: the Company’s VY-HTT01 IND submission to the FDA lacked key information regarding certain chemistry, manufacturing and controls (“CMC”) matters, including, inter alia, drug-device compatibility and drug substance and product characterization; the Company’s IND submission for VY-HTT01 was therefore deficient; the Company h